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Background: Listeria monocytogenes is an intracellular pathogen that invades the host cytoplasm.
Results: Cells deficient in TLR2 and NOD2 show defective autophagy of Listeria monocytogenes.
Conclusion: Autophagy of Listeria is dependent on ERK pathway that is perturbed in TLR2- and NOD2-deficient cells.
Significance:Our study establishes the role of innate immune receptors in autophagy of intracellular pathogens.
Listeria monocytogenes is a facultative intracellular pathogen
that invades both phagocytic and non-phagocytic cells. Recent
studies have shown thatL. monocytogenes infection activates the
autophagy pathway. However, the innate immune receptors
involved and the downstream signaling pathways remain
unknown. Here, we show that macrophages deficient in the
TLR2 and NOD/RIP2 pathway display defective autophagy
induction in response to L. monocytogenes. Inefficient
autophagy inTlr2/ andNod2/macrophages led to a defect
in bacteria colocalization with the autophagosomal marker
GFP-LC3. Consequently, macrophages lacking TLR2 and
NOD2 were found to be more susceptible to L. monocytogenes
infection, as were the Rip2/mice. Tlr2/ andNod2/ cells
showed perturbed NF-B and ERK signaling. However,
autophagy against L. monocytogenes was dependent selectively
on the ERK pathway. In agreement, wild-type cells treated with
a pharmacological inhibitor of ERK or ERK-deficient cells dis-
played inefficient autophagy activation in response to L. mono-
cytogenes. Accordingly, fewer bacteria were targeted to the
autophagosomes and, consequently, higher bacterial growth
was observed in cells deficient in the ERK signaling pathway.
These findings thus demonstrate that TLR2 and NOD proteins,
acting via the downstream ERK pathway, are crucial to
autophagy activation and provide a mechanistic link between
innate immune receptors and induction of autophagy against
cytoplasm-invading microbes, such as L. monocytogenes.
Listeriamonocytogenes is aGram-positive food-borne patho-
gen that causes listeriosis, a severe form of gastroenteritis with
a possible nervous system infection, particularly in immuno-
compromised individuals, pregnant women, and neonates (1,
2). L. monocytogenes mediates its own uptake into phagocytic
cells and non-phagocytic cells (e.g. enterocytes, hepatocytes,
fibroblasts, and endothelial cells) via bacterial invasion factors
called internalins (3, 4). Once inside the phagosome, a decrease
in pH activates Listeria cytolysin listeriolysin O. Listeriolysin O
then blocks phagolysosomal fusion and degrades the vacuolar
membrane, leading to the escape of L. monocytogenes into the
cytosol (5, 6). 90 min after infection, approximately 80% of
the L. monocytogenes are observed in the cytosol (7). Entry into
the cytoplasm is also assisted by phosphatidylinositol phospho-
lipase C and phosphatidylcholine phospholipase C two bacte-
rial phospholipases that hydrolyze host lipids to produce diacyl-
glycerol and inositol phosphate, and ceramide, respectively,
additionally playing a major role in subverting host cellular
responses (8, 9). Three to five hours after infection, L. monocy-
togenes in the cytosol utilizes its ActA protein to polymerize
host actin forming comet-like tail that propels bacterial move-
ment and spread from cell to cell (10).
The innate immune response depends on pathogen recogni-
tion receptors for detection of pathogen-associated molecular
patterns. These receptors include Toll-like receptors (TLRs),2
RIG-I-like receptors, and Nod-like receptors (NLRs) family of
proteins (11). TLRs are transmembrane proteins for sensing
extracellular pathogens whereas NLRs sense pathogen-associ-
ated molecular patterns in the cytosolic compartment. NLRs
consist of more than 20 family members, including Nucleotide
Oligomerization domain 1 (NOD1), NOD2, NLRP3, and
NLRC4 (12–14). NOD1 is expressed ubiquitously, whereas
NOD2 is expressed mainly in the myeloid cells such as macro-
phages and dendritic cells (DCs) (12). NOD1/NLRC1 and
NOD2/NLRC2 recognize peptidoglycan components -D-glu-
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tamyl-meso-diaminopimelic acid and muramyl dipeptide,
respectively (15, 16). L. monocytogenes activates a cytosolic sur-
veillance system that results in the expression of interferon
-regulated genes. Furthermore, host defense against L. mono-
cytogenes is mediated by the secretion of IFN- , TNF, IL-1,
IL-6, IL-12, IL-18, CCL2, MIP2, CXCL1, and the coexpression
of costimulatorymoleculesCD40,CD80, andCD86on antigen-
presenting cells (17, 18).
Autophagy is a highly conserved cellular catabolic process
that removes damaged organelles and degrades long-lived pro-
teins during periods of starvation, thereby playing a crucial role
during cell survival and death (19–21). Autophagy also has an
essential role in the innate defensemechanism, i.e. it eliminates
cytoplasm-invading microbes by forming a double-layered
membrane that wraps around the cytosolic bacteria so that it
can be degraded via fusion with lysosomes (22–26). Autophagy
was recently shown to be protective in elimination of bacterial
pathogens (27–30). In the context of L. monocytogenes, earlier
reports have shown that TLR2 and NOD proteins play a pro-
tective role during L. monocytogenes infection. TLR2 is
required for macrophage activation (31–33). Similarly, the
NOD1-NOD2/RIP2 pathway has been shown to be critical for
host defense against L. monocytogenes in vitro and in vivo (34,
35). However, the role of extracellular TLRs and the cytosolic
NOD proteins in autophagy of L. monocytogenes remain
unknown. Here we show that the innate immune receptors
TLR2 and NOD/RIP2 pathways activate autophagy via ERK
activation, leading to degradation of L. monocytogenes within
autophagosomes.
EXPERIMENTAL PROCEDURES
Reagents—All reagents were obtained from Sigma unless
otherwise stated. The following antibodies were used: anti-LC3
from Novus Biologicals, anti-ERK, anti-phospho-pERK, anti-
IB, anti-pIB (Cell SignalingTechnology, Inc.), anti-actin, and
anti-tubulin (Sigma). HRP-labeled anti-rabbit and anti-mouse
antibodies were obtained from Jackson ImmunoResearch Lab-
oratories, Inc. All fluorescently labeled secondary antibodies
were obtained fromMolecular Probes (Invitrogen). Rapamycin
was obtained from LC Laboratories. NF-B inhibitor SN50
(catalog no. 481480) and MEK inhibitor PD98059 (catalog no.
513000) were obtained from Calbiochem.
Mice and Macrophage Culture—Nod1/, Nod2/,
Rip2/, Tlr2/, Tlr4/ mice backcrossed to the C57BL/6
background for at least 10 generations have been described
before (57, 58). Allmicewere housed in a pathogen-free facility.
Bone marrow-derived macrophages were prepared from the
femurs of 6- to 10-week-old male mice by using supernatant
from L cells as differentiation medium.
Bacterial Strains and Infection of Macrophage/Dendritic
Cells and Mice—Wild-type L. monocytogenes and isogenic
mutants were grown in brain heart infusion medium at 37 °C
overnight to mid-log phase for macrophage infections. Briefly,
L. monocytogenes were washed twice with PBS and macro-
phages were infected for 30 min with a multiplicity of infection
of 1:1 unless stated otherwise, and the medium was replaced
with fresh medium. After 45 min of infection, gentamicin (10
g/ml) was added to limit the growth of extracellular bacteria.
Where mentioned, CQ (50 M) was added 30 min after infec-
tion. Where mentioned, NF-B inhibitor SN50 (15 M) or
MEK inhibitor PD98059 (50 M) were preincubated with
macrophages 1 h before infection and maintained during the
course of the experiment.
For in vivo experiments, adult mice (6–10 weeks old) were
used. For infection, wild-type and Rip2/mice were infected
intraperitoneallywith 3 105L. monocytogenes. Bacterial loads
in the liver and spleen were determined on day 3 after infection
by serial dilution of the lysates on brain heart infusionmedium.
Western Blotting—At different times after infection, cells
were lysed in radioimmune precipitation assay lysis buffer sup-
plemented with complete protease inhibitor mixture (Roche)
and PhosSTOP (Roche). Lysates were resolved on SDS-PAGE
and transferred to PVDFmembranes by electroblotting. Mem-
braneswere blocked in 5%nonfatmilk and incubated overnight
with primary antibody at 4 °C and for 1 h with secondary HRP-
tagged antibody at room temperature. The membranes were
developed with ECL (Pierce).
Nucleofection, Immunofluorescence, and Transmission Elec-
tron Microscopy—Cells were resuspended in nucleofector
buffer (Amaxa) at a density of 2  106 with 2 g of GFP-LC3
plasmid. Cells were nucleoporated according to the manufac-
turer’s instructions (Amaxa) and seeded onto glass coverslips.
After 4 h, cells were infected with L. monocytogenes at a multi-
plicity of infection of 1:1. The cellswere fixed at the desired time
points with 4% paraformaldehyde and processed for immuno-
flourescence as described previously (59). Cells on coverslips
were mounted on slides with ProLong anti-gold antifade rea-
gent (Invitrogen) and analyzed with a Nikon C1 confocal
microscope with a40 objective lens using the manufacturer’s
original software. The images were processed later with the
ImageJ program.
For transmission electron microscopy, cells were fixed in a
solution of 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH
7.4). Cells were then embedded and sectioned for transmission
electronmicroscopy by theCell andTissue ImagingCore Facil-
ity of St. Jude Children’s Research Hospital.
Intracellular Growth Curves—Cells were grown on cover-
slips and infected with L. monocytogenes at a multiplicity of
infection of 1:1 as described above. Intracellular growth curves
of L. monocytogenes were generated as described previously
(60).
Statistics—Quantifications of the number of autophago-
somes per cell and LC3 - positive L. monocytogenes were per-
formed by direct visualization on a Nikon C1 confocal micro-
scope. For intracellular growth curves, at least three
independent experiments were done in triplicate, and the
means  S.E. are reported. p values were calculated using the
two-tailed Student’s t test. Densitometry analysis of the immu-
noblotswas performedby the ImageJ program. Bacterial counts
of infected mice were analyzed by Mann-Whitney U test.
RESULTS
L. monocytogenes Infection Induces Autophagy in Bone Mar-
row-derived Macrophages—L. monocytogenes is an intracellu-
lar pathogen that escapes the phagosome and replicates in the
host cytosol. Recent studies have suggested that cytoplasm-in-
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vading bacteria are targets for degradation by autophagy (36).
L. monocytogenes was observed to induce autophagy and colo-
calized with autophagosomes in mouse embryonic fibroblasts
and RAW 264.7 macrophages (27, 37). We first evaluated
whether L. monocytogenes induces autophagy in bonemarrow-
derived macrophages by employing autophagy marker, LC3, as
a readout (38). LC3 is present inmammalian cells as a cytoplas-
mic form (LC3-I) or in a membrane-associated form (LC3-II).
LC3-I is lipidated by phosphatidylethanolamine (LC3-PE) to
the LC3-II form that associates to the autophagosome mem-
brane and migrates on SDS-PAGE with a downward shift in
molecular weight.
First, we infected macrophages with L. monocytogenes for
0.5 h at 37 °C. At different times post-infection, protein
lysates were collected. As shown in Fig. 1A, control cells
showed only basal levels of autophagy. However, there was a
time-dependent increase in LC3-II expression after infec-
tion with the pathogen. Using this antibody, LC3-I was
barely detectable because of the lower sensitivity of the pres-
ently available anti-LC3 antibodies for LC3-I (39). Further,
this response was not dependent on the bacterial dose
because LC3-II expression increased equally well at a higher
multiplicity of infection (Fig. 1A, right panel).
As the processing of LC3-I to LC3-II increases, there is a
corresponding increase in autophagosome formation (40). We
next employed GFP-LC3 to observe this phenomenon. Unin-
fected macrophages transfected with GFP-LC3 showed diffuse
cytoplasmic distribution of the protein (Fig. 1B, left panel).
However, after infection with L. monocytogenes, an increase in
autophagosomes in the formofGFP-LC3punctawere observed
(Fig. 1B, right panel) that was approximately 4 times more than
in control cells (Fig. 1C). We also observed autophagy at the
ultrastructure level by electron microscopy. As shown in Fig.
1D, autophagosomes showing double-membraned structures
were observed after infection with L. monocytogenes.
LC3-II associates with both the outer and the inner mem-
brane of autophagosomes. As autophagosomes mature by
fusion with lysosomes, LC3-II present on the inner membrane
of this organelle is also degraded (38, 39). An increase in LC3-II
levels indicates either enhanced autophagosome formation or
decreased turnover of LC3-II (or autophagic flux) caused by
delayed fusion with lysosomes. To better interpret the increase
in LC3-II levels after L. monocytogenes infection, we treated
macrophages with chloroquine (CQ), a lysosomotropic agent
that inhibits autophagosome fusion with lysosomes and there-
fore autophagic degradation. As expected, control cells treated
with CQ showed an increase in the expression of the lipidated
LC3-II form that showed a similar higher trend when infected
macrophages were treated with CQ (Fig. 1E), suggesting the
presence of an efficient autophagic flux.
TLR2 Is Required for Autophagy Activation upon L. monocy-
togenes Infection—Infection with L. monocytogenes led to
autophagy induction. Thus, we sought to decipher the molec-
ular sensor for host cells that triggers autophagy after L. mono-
cytogenes infection. We first focused on the role of TLR2 in
autophagy activation upon L. monocytogenes infection. Macro-
phages, either wild-type (WT) or Tlr2/, were infected with
L. monocytogenes, andLC3 lipidationwas evaluated byWestern
blotting (WB) 2 h and 4h after infection. Cells deficient inTLR2
showed inefficient autophagy induction after infection with
L. monocytogenes (Fig. 2A and B). However, a normal
autophagic response was induced with rapamycin, a classical
FIGURE 1. L. monocytogenes infection induces autophagy in bone marrow-derived macrophages. A, Western blot analyses of LC3-II in macrophages
either uninfected (C) or infected with L. monocytogenes (Lm) either at a multiplicity of infection of 1:1 or 5:1. Actin was used as a loading control. B and C,
confocalmicroscope images ofmacrophages nucleofectedwith theGFP-LC3plasmid andeither uninfected (control) or infectedwith L. monocytogenes. At 4 h,
cells were fixed and analyzed for the number of autophagosomes per cell as shown in C. Scale bars 10m. Values represent mean S.E. *, p 0.05.D, cells
infected as described above were fixed in 2.5% gluteraldehyde and processed for transmission electron microscopy. L. monocytogenes, either within an
autophagosome (arrow) or free in the cytoplasm (arrowheads) are indicated. E, Western blot analyses of cells infected as described above. At 30 min, a set of
control and L. monocytogenes-infected cellswere incubatedwith chloroquine. The lysateswere prepared 4h after infection. Results are representative of three
separate experiments.
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inducer of autophagy (Fig. 2A), thus indicating that autophagy
induction only in response toL. monocytogenes is compromised
in Tlr2/ cells. TLR4 has no role in L. monocytogenes recog-
nition. In agreement, Tlr4/ macrophages showed LC3-II
induction comparable with that of WT macrophages (Fig. 2, A
and B). Further, autophagic flux in control or infected cells,
measured after exposure to CQ, was found to be equally effi-
cient (Fig. 2A).
We next used GFP-LC3 to determine the formation of
autophagosomes inWT andTlr2/ cells. Transfection ofWT
macrophages showed distinct GFP-LC3 punctate structures
after infection with L. monocytogenes (Fig. 2C). Consistent with
our WB data, the number of GFP-LC3 puncta were markedly
reduced in TLR2-deficient cells infected with L. monocytogenes
(Fig. 2, C and D). This was not because of reduced uptake, as it
was found to be similar in wild-type and Tlr2/macrophages
(supplemental Fig. S1A). The induction of autophagosome for-
mation was normal when these cells were treated with rapamy-
cin (Fig. 2, C and D). These data demonstrate that autophagy
induction upon L. monocytogenes infection is dependent on
TLR2 signaling.
NOD1 and NOD2 Are Required for Autophagy Activation
upon L. monocytogenes Infection—Soon after its entry into a
phagosome within a host cell, L. monocytogenes escapes into
the cytosol, where it is recognized by intracellular receptors
NOD1 and NOD2 (35, 41). To resolve whether any of these
cytosolic receptors are required for activation of autophagy, we
next infected Nod1/ or Nod2/ macrophages with
L. monocytogenes and evaluated LC3 lipidation by WB at vari-
ous times post-infection. Cells that were deficient in either
NOD1 or NOD2 showed a marked reduction in autophagy
induction. However, these cells showed a normal autophagic
response to rapamycin (Fig. 3, A and B). Further, autophagic
flux in control or infected cells, measured after exposure to CQ,
was found to be equally efficient (Fig. 3A).
We next infected GFP-LC3 transfected macrophages with
L. monocytogenes. Consistent with our WB data, fewer GFP-
LC3 puncta were seen in NOD1- or NOD2- deficient cells
infectedwithL. monocytogenes as comparedwithWTcells (Fig.
3, C and D). This was not because of reduced uptake, as it was
found to be similar in WT and Nod1/ or Nod2/ macro-
phages (supplemental Fig. S1A). The induction of autophago-
FIGURE 2. TLR2 is required for autophagy activation upon L. monocytogenes infection. A, Western blot analyses of LC3-II in WT, Tlr2/, or Tlr4/
macrophages that were uninfected (C), infected with L. monocytogenes (Lm) for different periods (in the presence or absence of CQ), or incubated with
rapamycin (Rap) (50g/ml) for 2 h. Actin was used as a loading control. B, densitometry scanning of the blots showing the ratio of LC3-II to actin in wild-type,
Tlr2/, or Tlr4/ macrophages at 4 h. The graph is a representation of three different blots. C, confocal microscope images of WT or TLR2-deficient
macrophages transfectedwith theGFP-LC3 plasmid and uninfected (control), infectedwith L. monocytogenes for 4 h, or treatedwith rapamycin (50g/ml) for
2 h. Scale bars 10m.D, quantification of the number of GFP-LC3 puncta per cell 4 h after infection as described in C. Results showmean S.E. (*, p 0.05)
of experiments done at least three times.
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some formation was normal when Nod1/ or Nod2/ cells
were treated with rapamycin, indicating that the response is
selective for L. monocytogenes infection (Fig. 3,C andD). These
results suggest that both NOD1 and NOD2 are essential for
induction of autophagy after infection of macrophages with
L. monocytogenes.
NOD1 and NOD2 signaling pathway involves the down-
streamadaptorRIP2 kinase. Earlier reports have suggested con-
tradictory results in regard to the role for RIP2 in autophagy
induction by stimulation with NOD ligands (42, 43). To inves-
tigate whether RIP2 is required for autophagy of L. monocyto-
genes, Rip2/ cells were infected with L. monocytogenes. Sim-
ilar to Nod1/ cells or Nod2/ cells, Rip2/ cells also
showed defective LC3-II induction as compared with WT
macrophages (Fig. 3, A and B). Further, uptake of L. monocyto-
genes was found to be similar both in WT and Rip2/macro-
phages (supplemental Fig. S1A). We also examined the forma-
tion of GFP-LC3 autophagosomes in Rip2/ macrophages
infected with L. monocytogenes. Fewer autophagosomes were
observed in Rip2/ cells, as indicated by fewer GFP-LC3
puncta (Fig. 3, C and E), suggesting that NOD1/NOD2-depen-
dent autophagy of L. monocytogenes proceeds via RIP2.
Tlr2/ and Nod2/ Macrophages Sequester Fewer
L. monocytogenes within Autophagosomes—To demonstrate
the role of NOD2 in autophagy, we next investigated, at the
ultrastructural level, autophagosome formation in WT and
NOD2-deficient macrophages infected with L. monocyto-
genes (Fig. 4A). Four hours post-infection, the Nod2/ cells
contained half the number of autophagosomes per cell than
did WT macrophages (Fig. 4B). To confirm this further, we
analyzed the colocalization of Listeria with autophagosomes
inmacrophages that wereWT, TLR2-, or NOD2-deficient by
using confocal fluorescence microscopy. GFP-LC3 express-
ing macrophages were infected with L. monocytogenes, and
the localization of the pathogen was determined using anti-
Listeria antibody (Fig. 4C). After infection, approximately
FIGURE 3. NOD1 and NOD2 are required for autophagy activation upon L. monocytogenes infection. A, Western blot analyses of LC3-II in WT, Nod1/,
Nod2/, or Rip2/macrophages that were uninfected (C), infected with L. monocytogenes (Lm) for different periods (in the presence or absence of CQ), or
incubatedwith rapamycin (Rap) (50g/ml) for 2 h. Actinwas used as a loading control. B, densitometry scanning of the blot showing the ratio of LC3-II to actin
in wild-type, Nod1/, Nod2/, or Rip2/macrophages at 4 h. The graph is a representation of three different blots. C, confocal microscope images of WT,
NOD1-, NOD2-, or RIP2-deficientmacrophages transfectedwith the GFP-LC3 plasmid. Cells were uninfected, infectedwith L. monocytogenes for 4 h, or treated
with rapamycin (50 g/ml) for 2 h. Scale bars  10 m. D and E, quantification of the number of GFP-LC3 puncta per cell at 4 h post-infection in Nod2/
macrophages or Rip2/macrophages (E) when infected as described in C. Results showmean S.E. (*, p 0.05) of experiments done at least three times.
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25% of the pathogen colocalized with GFP-LC3 autophago-
somes in WT cells, whereas in TLR2- and NOD2-deficient
macrophages, approximately 16 and 15% of the L. monocy-
togenes were found in GFP-LC3-positive vacuoles, respec-
tively, 4 h after infection (Fig. 4D). Similar results were
observed in Rip2/ cells (supplemental Fig. S2A). L. mono-
cytogenes ActA protein is responsible for actin-based motil-
ity in the cytosol, and it has been shown recently that Listeria
mutants lacking ActA are more efficiently targeted to
autophagosomes (44). Evaluation of autophagy of the Liste-
ria ActA mutant revealed that a remarkably higher percent-
age (37%) of the mutant Listeria is in autophagosomes in
wild-type macrophages (Fig. 4E). However, Tlr2/ and
Nod2/ macrophages showed only 18 and 16% of the
mutant Listeria within autophagosomes, respectively (Fig.
4E). To directly test the role of TLR2 and NOD2 in limiting
FIGURE 4. Tlr2/ and Nod2/ macrophages sequester fewer L. monocytogenes within autophagosomes. A, electron micrograph of WT and NOD2-
deficient macrophages infected with L. monocytogenes. Arrows denote L. monocytogenes either within the autophagosome (left panel) or free in the cytosol
(right panel).B, quantificationof thenumber of autophagosomesper cell inmacrophages infected as described inA.C, confocalmicroscope images ofGFP-LC3
autophagosomes and Listeria fromWT, Tlr2/, and Nod2/ cells 4 h after infection. Scale bars 10 m. D, quantification of the GFP-LC3-positive L. mono-
cytogeneswild-type strain in cells infected as described in C. E, quantification of theGFP-LC3-positive Listeriamutant lacking ActA in cells infected as described
inC. F, intracellular growth curveof L. monocytogenes inwild-type, Tlr2/, andNod2/macrophages. *,p0.05.G, wild-typeandRip2/micewere infected
with 3  105 L. monocytogenes. The Western blot analysis shows LC3-II expression in liver homogenates from WT and Rip2/-infected mice at day 3 of
infection. Actinwasusedas a loading control.H, wild-type andRip2/micewere infectedasdescribed in F. Bacterial loadsweredetermined in liver and spleen
at day 3 after infection. Data represent the mean S.E. of three independent experiments. *, p 0.05. I, densitometry scanning of the Western blot analysis
showing the ratio of LC3-II to actin inwild-type and Tlr2/Nod2/macrophages infectedwith L. monocytogenes at 4 h. The graph is a representation of three
different blots.
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L. monocytogenes growth, we next compared the growth of
the pathogen in WT macrophages with that in Tlr2/ or
Nod2/ macrophages at various times after infection. A
modest but statistically significant increase in colony form-
ing units was observed in Tlr2/ or Nod2/ cells (Fig. 4F),
suggesting that TLR2 and NOD2 limit the growth of Listeria
by autophagy.
Next, we asked whether autophagy could restrict the growth
of the pathogen in vivo. To perform this, we infected WT and
Rip2/ mice with L. monocytogenes. Liver homogenates, col-
lected 3 days after infection, were assayed for LC3 levels by
SDS-PAGE. LC3-II levels in infected WT mice increased as
compared with mice that were uninfected (Fig. 4G). However,
Rip2/ mice showed defective autophagy activation, as
observed by reduced LC3-II levels in these samples (Fig. 4G). In
accordance with reduced autophagy, Rip2/mice showed an
increased bacterial burden in the liver and spleen (Fig. 4H). In
agreement with the role forNOD1/2 adaptor RIP2, TLR2 adap-
tor MyD88-deficient mice also show increased Listeria growth
in vivo (45).
Next, we tested howTLR2 andNOD2cooperate in activating
autophagy in response to L. monocytogenes infection. To test
this, wemade use ofTlr2/Nod2/ double knockoutmacro-
phages. LC3-II levels increased after infection inwild-type cells.
However, to our surprise, even the absence of both TLR2 and
NOD2 did not abolish LC3-II levels completely (Fig. 4I and
supplemental Fig. S2B), indicating the presence of other redun-
dant pathways that are activated to compensate for autophagy
induction in the absence of both TLR2 and NOD2 signaling.
TLR2/ and Nod2/Macrophages Show Defective NF-B
and ERK1/2 Signaling upon Listeria Infection—To determine
the signalingmechanisms that regulate autophagy downstream
of TLR2 and NOD2 in L. monocytogenes-infected cells, we pre-
pared cell lysates from WT, Tlr2/, and Nod2/ macro-
phages at various times post-infection and determined the lev-
els of NF-B and ERK1/2 activation by immunoblotting. At 2 h
and later post-infection, we observed increased autophagy
induction against L. monocytogenes in wild-type cells that was
defective in Tlr2/ and Nod2/ cells (Fig. 5A, lower panel).
Upon immunoblotting with specific antibodies, we found
increased phosphorylation of I-B and ERK1/2 in WT cells
(Fig. 5A, upper panels). In contrast, these signaling pathways
were perturbed inTlr2/ andNod2/macrophages infected
with L. monocytogenes (Fig. 5A). We also tested these signaling
pathways in cells deficient in NOD2 adaptor protein RIP2. As
we also demonstrated before (Figs. 3A and 5B, lower panel),
Rip2/ cells were inefficient in LC3-II induction as compared
withwild-type cells. Similar toTlr2/ andNod2/, cells defi-
cient in RIP2 also displayed perturbed NF-B and ERK signal-
ing when exposed to L. monocytogenes (Fig. 5B, upper panels).
Autophagy of L. monocytogenes Is Dependent on the ERK Sig-
naling Pathway—We next sought to test whether the NF-B
and ERK signaling pathways that are defective in Tlr2/ and
Nod2/ macrophages (Fig. 5A) are directly associated with
autophagy of L. monocytogenes. To investigate this,WTmacro-
phages were infected with L. monocytogenes in the presence of
inhibitors specific for these signaling pathways. Infection with
L. monocytogenes led to an increase in autophagy levels. How-
ever, treatment of infected cells with NF-B inhibitor peptide
SN50 did not change LC3-II expression (Fig. 6A). We also con-
firmed this result by inhibition of NF-B activation by SC-514,
an IKK2 inhibitor, which showed similar results (Fig. 6B), indi-
cating no role for NF-B in autophagy of Listeria. In contrast,
treatment with PD98059, an inhibitor of the MEK signaling
pathway abolished any increase in autophagy (Fig. 6C), suggest-
ing the specificity of the MEK/ERK signaling pathway in
autophagy of L. monocytogenes infection.
We next employed GFP-LC3 to look for Listeria-targeted
autophagosomes in control cells or cells that were exposed to
the ERK inhibitor PD98059. In control macrophages, 35% of
L. monocytogenes ActA were found within autophagosomes.
However, only 20% of Listeria was observed inside GFP-LC3
vacuoles in macrophages treated with PD98059 (Fig. 6D). Con-
sistent with this, more growth of the pathogen was observed in
cells treatedwith the ERK inhibitor (Fig. 6E).Wenext tested the
effect of the ERK inhibitor on Nod2/ cells that are already
defective in autophagy. Exposure of Nod2/ cells to the ERK
inhibitor did not show any change in LC3-II levels (supplemen-
tal Fig. S3A). In agreement, no significant effect on colony
counts was observed when Nod2/ cells were exposed to the
ERK-inhibitor (supplemental Fig. S3B).
FIGURE 5. TLR2/ andNod2/macrophages showdefectiveNF-Band
ERK1/2 signaling upon Listeria infection. A, Western blots of pIB, IB,
pERK, ERK, and LC3-II in WT, TLR2-, and NOD2-deficient macrophages that
were uninfected (C) or infected with L. monocytogenes for different periods.
Tubulin was used as a loading control. B, Western blot analyses of pIB, IB,
pERK, ERK, and LC3-II in WT and RIP2-deficient macrophages that were unin-
fected (C) or infected with L. monocytogenes for different periods.
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Cells Deficient in ERK Signaling Display Defective Autophagy
of L. monocytogenes—We next confirmed the role for ERK in
autophagy of L. monocytogenes by employing Erk1/;Erk2fl/
fl;CD11c-Cre (Erk-DKO) DCs. As a control, we first tested the
role for GM-CSF-differentiated dendritic cells in autophagy
activation against L. monocytogenes in WT and Nod2/ den-
dritic cells. Similar to our results with macrophages, L. mono-
cytogenes infection activated autophagy in WT DCs. However,
Nod2/DCs did not show an efficient induction of autophagy
(Fig. 7A), suggesting that defective autophagy of Listeria is not
restricted solely to Nod2/ macrophages. Also, treatment
withCQ to explore the processing of LC3-II showed an increase
in LC3-II lipidation, thereby suggesting the presence of func-
tional autophagolysosomes in these cells.We next exposedWT
and Erk-DKO DCs to L. monocytogenes. As shown in Fig. 7B,
Erk-DKO DCs displayed defective autophagy activation upon
L. monocytogenes infection. Autophagy induction was reduced
by almost one-half in knockout cells as comparedwithWTDCs
when exposed to L. monocytogenes (Fig. 7C).
We next employed GFP-LC3 to determine the formation of
autophagosomes in WT and Erk-DKO cells. Consistent with
our WB data, the number of GFP-LC3 puncta per cell was
markedly reduced in Erk-DKO cells (Fig. 7D). This was not
because of reduced uptake in knockout cells, as it was similar in
both cell types (supplemental Fig. S1B). To confirm further, we
enumerated the number of L. monocytogenes localized to GFP-
LC3 autophagosomes. In wild-type cells, approximately 25% of
L. monocytogenes colocalized with GFP-LC3 autophagosomes,
whereas less than 15% of the pathogen localized with the
autophagosomes in Erk-DKO cells (Fig. 7E). Because Listeria
mutants lacking ActA are more efficiently targeted to autopha-
gosomes (44), we observed approximately 35% of the mutant
bacteria in GFP-LC3 vacuoles, whereas 17% of L. monocyto-
genes lacking ActA were observed in autophagosomes in
knockout cells (Fig. 7F). To directly test the role of ERK-depen-
dent autophagy in L. monocytogenes infection, we compared
the growth of the Listeria ActA mutant in WT and Erk-DKO
cells. A significant increase in L. monocytogenes growth was
observed in cells lacking the ERK1/2 pathway (Fig. 7G), sug-
gesting the restriction of the bacteria by ERK-dependent
autophagy.
DISCUSSION
Autophagy plays a crucial role in innate immune response to
intracellular pathogens (24–26, 46). Intracellular pathogens are
taken up into phagosomes, wherein many of them are killed by
acidification of this compartment after fusion with lysosomes.
However, various other intracellular pathogens have evolved
strategies to escape phagolysosomal killing. For example, Cox-
iella survives in an acidic compartment, whereas pathogens like
Mycobacteria inhibit phagolysosomal killing and therefore
inhabit an endosome/phagosome-like compartment (47). Still
others, like L. monocytogenes, evade phagolysosomal killing by
escaping into the cytoplasm (48). Although pathogens have
evolved mechanisms to evade killing in the phagosome, their
mammalian hosts have coevolved alternative mechanisms to
limit their growth. Autophagy is one such mechanism that is
particularly important in eliminating bacteria that invade cyto-
plasm. Here we demonstrate that autophagy against L. mono-
cytogenes is mediated by the extracellular TLR2 and intracellu-
lar NOD/RIP2 pathways.We showed that autophagy induction
through this pathway leads to the sequestration of L. monocy-
togeneswithin autophagosomes, leading to decrease in bacterial
survival.
Recent studies reported the induction of autophagy by
L. monocytogenes (49) and colocalization ofL. monocytogenes in
autophagosomes in the early phase of infection by mouse
embryonic fibroblasts and RAW 264.7 macrophages (27, 36,
37). This process depends on ActA and bacterial phospho-
lipases PI-PLC and PC-PLC. Another recent study described
that Listeria-ActA mutants are more efficiently targeted to
autophagosomes than wild-type Listeria because ActA helps in
recruitment of host actin machinery, thereby escaping
autophagy recognition (44). Zhao et al. (50) observed that mice
lacking Atg5 in macrophages and granulocytes are more sus-
ceptible to L. monocytogenes infection. Similarly, Yano et al.
(51) reported an essential role for autophagy in increased sur-
FIGURE 6. Autophagy of L. monocytogenes is dependent on the ERK sig-
nalingpathway.A,Westernblot analyses of LC3-II inwild-typemacrophages
left uninfected (control), infected with L. monocytogenes in the absence or
presence of NF-B inhibitor SN50, or treated with SN50 alone. Tubulin was
used as a loading control. B, Western blot analyses of LC3-II in wild-type
macrophages left uninfected (control), infectedwith L. monocytogenes in the
absence or presence of NF-B inhibitor SC-514, or treated with SC-514 alone.
Tubulin was used as a loading control. C, Western blots of LC3-II in wild-type
macrophages left uninfected (control), infectedwith L. monocytogenes in the
absenceor presence of the ERK inhibitor (PD98059), or treatedwith the inhib-
itor alone. Tubulinwas used as a loading control.D, quantification of GFP-LC3
positive Listeria ActA mutant in wild-type cells in the absence or presence of
the ERK inhibitor. *, p 0.05. E, intracellular growth curve of the L. monocyto-
genes ActA mutant in wild-type cells in the absence or presence of the ERK
inhibitor. *, p 0.05.
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vival ofDrosophila that depends on the recognition of L. mono-
cytogenes by the peptidoglycan recognition receptor. Collec-
tively, these findings suggest that L. monocytogenes induces
autophagy and that Listeria ActA mutants are more efficiently
sequestered within autophagosomes during the early phase of
infection.
We observed that NOD1 and NOD2 are crucial for
autophagic recognition of L. monocytogenes. NOD proteins
have been shown very recently to be critical for autophagy
induction in response to their specific ligands. Consequently,
autophagywas shown to be important in recognition of Shigella
and Salmonella in DCs (42, 43). Mutations in NOD2 and an
essential autophagy gene, ATG16L1, are associated with
Crohn’s disease, which results from an excessive inflammatory
response to normal gut flora (52–55). In line with this, the
induction of autophagy via NOD2 was shown to be dependent
on Atg16L1. However, contrasting results were reported in
regard to the requirement for RIP2 in autophagy (42, 43). In line
withCooney et al. (43), our study clearly demonstrated a critical
role for RIP2 in autophagy of L. monocytogenes in vitro and in
vivo.
Autophagy in response to limiting nutrients proceeds
through inactivation of mammalian target of rapamycin pro-
tein kinase and is dependent on phosphatidylinositol-3 kinase
FIGURE 7. Cells deficient in ERK signaling display defective autophagy of L. monocytogenes. A, Western blot analyses of LC3-II in wild-type and Nod2/
dendritic cells infected with L. monocytogenes. At 30 min, a set of control and L. monocytogenes-infected cells were incubated with CQ. Results are represent-
ative of three separate experiments. B, Western blot analyses of LC3-II in wild-type and Erk1/;Erk2fl/fl;CD11c-Cre (ERK-DKO) DCs infected with L. monocyto-
genes. Results are representative of three separate experiments. C, densitometry scanning of the Western blot analysis showing the ratio of LC3-II to actin in
wild-type and ERK-DKO DCs infected with L. monocytogenes 4 h after infection. D, quantification of the number of GFP-LC3 puncta per cell 4 h after infection
in wild-type and ERK-DKO DCs. Results show mean  S.E. (*, p  0.05) of experiments done at least three times. E, quantification of the GFP-LC3-positive
L. monocytogenes wild-type strain in cells infected as described in C. Results show mean  S.E. (*, p  0.05) of experiments done at least three times. F,
quantificationof theGFP-LC3-positive Listeriamutant lackingActA in cells infectedasdescribed inC. Results showmeanS.E. (*,p0.05) of experimentsdone
at least three times. G, intracellular growth curve of L. monocytogenes ActA in wild-type and ERK-DKO DCs. *, p 0.05.
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hVps34/Beclin-1 complex (19, 21, 56). However, the upstream
signaling components involved that regulate autophagy in
response to L. monocytogenes infection have not been identi-
fied. Our results show that besides the NOD/RIP2 pathway,
TLR2 is also required for autophagy against L. monocytogenes.
Consequently, we observed significantly less L. monocytogenes
colocalizing with GFP-LC3 autophagosomes in Tlr2/
macrophages. Further, both NF-B and ERK signaling path-
ways are perturbed in Tlr2/ and Nod2/ macrophages.
However, autophagy against L. monocytogenes was resistant to
the NF-B inhibitor in WT macrophages. In contrast, cells
exposed to the pharmacological inhibitor of the MEK/ERK
pathway or Erk-DKO cells displayed reduced autophagy activa-
tion against L. monocytogenes, implicatingMEK/ERK signaling
in regulating L. monocytogenes-induced autophagy. Our data
showing a critical role for ERK signaling during autophagy of
Listeria thus implicates the ERK pathway in initiating antibac-
terial autophagy for the first time.
In summary, we have elucidated an important link between
innate immune receptors and the induction of autophagy
against cytoplasm-invadingL. monocytogenes. Our data suggest
that TLR2 and the NOD/RIP2 axis are essential pathways
through which autophagy is initiated to limit the survival of
microbes. Consequently, these findings may lead to the devel-
opment of novel therapeutic interventions that modulate
autophagy.
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